维力医疗：将结合公司发展战略 择机在海南布局更多业务

Core Viewpoint - Weili Medical (603309) is leveraging the opportunities presented by the Hainan Free Trade Port, focusing on expanding its business in the region while adhering to regulatory requirements for information disclosure [1] Group 1: Company Operations - The company has a wholly-owned subsidiary and an automated production base for latex catheters located in Hainan [1] - The main raw material for latex catheters is imported latex, which benefits from duty-free imports and processing value-added duty exemptions [1] Group 2: Strategic Focus - The company is closely monitoring policy developments related to the Hainan Free Trade Port and plans to align its business strategies accordingly [1] - Future investments in Hainan will be made in accordance with the company's development strategy and regulatory guidelines [1]